Literature DB >> 30034939

KLF4 suppresses the migration of hepatocellular carcinoma by transcriptionally upregulating monoglyceride lipase.

Xuejun Yang1,2, Dongmei Zhang1,2, Sha Liu1,2, Xiaojie Li1,2, Wanglai Hu3, Chuanchun Han1,2.   

Abstract

The dysregulation of cellular metabolism, particularly lipid metabolism, is essential for cancer progress. Monoglyceride lipase (MGLL) is an important fatty acid metabolism enzyme, which converts monoacylglycerides to free fatty acids and glycerol. Despite the expression level of MGLL was reported to be downregulated in Hepatocellular carcinoma (HCC), the clinical significances and molecular mechanism of MGLL downregulation remains unknown. In the current study, the clinical significances of MGLL expression were investigated in 95 patients with HCC and the transcription factors of MGLL were identified in HCC cells. We found that MGLL was frequently downregulated in HCC samples, especially in metastatic tumor tissues. Patients with low MGLL expression owned remarkably lower 5 year-overall survival (5-OS). Functionally, we found that MGLL played an important role in HCC cell migration. Overexpression of MGLL suppressed cell migration and depletion of MGLL by shRNA promoted cell migration. Further studies indicated that KLF4 directly bound to the promoter of MGLL and accelerated MGLL expression, which then led to HCC cell migration decrease. Additionally, the expression levels of KLF4 were positive association with MGLL expression in HCC tissues. Collectively, our data suggest that KLF4 is a key regulator of MGLL. The KLF4-MGLL axis plays an essential role in suppressing HCC cell migration.

Entities:  

Keywords:  KLF4; MGLL; hepatocellular carcinoma; lipid metabolism; migration

Year:  2018        PMID: 30034939      PMCID: PMC6048399     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  16 in total

1.  IDH1, a CHOP and C/EBPβ-responsive gene under ER stress, sensitizes human melanoma cells to hypoxia-induced apoptosis.

Authors:  Xuejun Yang; Tongde Du; Xiang Wang; Yingqiu Zhang; Wanglai Hu; Xiaofeng Du; Lin Miao; Chuanchun Han
Journal:  Cancer Lett       Date:  2015-06-03       Impact factor: 8.679

Review 2.  The role of monoacylglycerol lipase (MAGL) in the cancer progress.

Authors:  Hong Qin; Zhi-hua Ruan
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

3.  Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy.

Authors:  Binbin Ma; Zhongbo Yuan; Li Zhang; Peng Lv; Ting Yang; Jinxia Gao; Ning Pan; Qiong Wu; Jiacheng Lou; Chuanchun Han; Bo Zhang
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-05-09       Impact factor: 4.739

4.  Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer.

Authors:  Lin Ye; Bo Zhang; Elena G Seviour; Kai-Xiong Tao; Xing-Hua Liu; Yan Ling; Jian-Ying Chen; Guo-Bin Wang
Journal:  Cancer Lett       Date:  2011-05-04       Impact factor: 8.679

5.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

Review 6.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

7.  Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.

Authors:  Valerie A Morris; Carrie L Cummings; Brendan Korb; Sean Boaglio; Vivian G Oehler
Journal:  Mol Cell Biol       Date:  2015-12-07       Impact factor: 4.272

8.  Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

Authors:  Daniel K Nomura; Jonathan Z Long; Sherry Niessen; Heather S Hoover; Shu-Wing Ng; Benjamin F Cravatt
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

9.  Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer.

Authors:  H Sun; L Jiang; X Luo; W Jin; Q He; J An; K Lui; J Shi; R Rong; W Su; C Lucchesi; Y Liu; M S Sheikh; Y Huang
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

10.  ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.

Authors:  Lu Zhang; Yuan Wang; Xiaojie Li; Xin Xia; Na Li; Ruiping He; Hongtao He; Chuanchun Han; Wenzhi Zhao
Journal:  Neoplasia       Date:  2017-09-21       Impact factor: 5.715

View more
  11 in total

1.  MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4.

Authors:  Wenjing Qi; Chengshun Gao; Li Zhang; Zhenming Gao; Jidong Sui; Chuanchun Han; Deguang Sun
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 2.  Aberrant lipid metabolism as a therapeutic target in liver cancer.

Authors:  Evans D Pope; Erinmarie O Kimbrough; Lalitha Padmanabha Vemireddy; Phani Keerthi Surapaneni; John A Copland; Kabir Mody
Journal:  Expert Opin Ther Targets       Date:  2019-05-10       Impact factor: 6.902

Review 3.  Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis.

Authors:  Jingyue Zhang; Yawen Song; Qianqian Shi; Li Fu
Journal:  Front Med       Date:  2021-05-11       Impact factor: 4.592

4.  Effect and Mechanism of miR-26a-5p on Proliferation and Apoptosis of Hepatocellular Carcinoma Cells.

Authors:  Wen-Jing Zhu; Ying Yan; Jiu-Wei Zhang; Yan-Dong Tang; Bo Han
Journal:  Cancer Manag Res       Date:  2020-04-30       Impact factor: 3.989

Review 5.  Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types.

Authors:  Agnieszka Taracha-Wisniewska; Grzegorz Kotarba; Sebastian Dworkin; Tomasz Wilanowski
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

6.  Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.

Authors:  Wei-Lin Wang; Uyanga Batzorig; Chin-Sheng Hung; Po-Li Wei; Chien-Yu Huang; Yu-Jia Chang
Journal:  Biomed Res Int       Date:  2022-02-07       Impact factor: 3.411

Review 7.  SP and KLF Transcription Factors in Cancer Metabolism.

Authors:  Emilia J Orzechowska-Licari; Joseph F LaComb; Aisharja Mojumdar; Agnieszka B Bialkowska
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

8.  A Multi-Omics Approach to Liver Diseases: Integration of Single Nuclei Transcriptomics with Proteomics and HiCap Bulk Data in Human Liver.

Authors:  Marco Cavalli; Klev Diamanti; Gang Pan; Rapolas Spalinskas; Chanchal Kumar; Atul Shahaji Deshmukh; Matthias Mann; Pelin Sahlén; Jan Komorowski; Claes Wadelius
Journal:  OMICS       Date:  2020-03-16

9.  MicroRNA-7 Targets the KLF4 Gene to Regulate the Proliferation and Differentiation of Chicken Primary Myoblasts.

Authors:  Genxi Zhang; Fuxiang Chen; Pengfei Wu; TingTing Li; Mingliang He; Xuemei Yin; Huiqiang Shi; Yanjun Duan; Tao Zhang; Jinyu Wang; Kaizhou Xie; Guojun Dai
Journal:  Front Genet       Date:  2020-09-18       Impact factor: 4.599

10.  Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it.

Authors:  Gehou Zhang; Guolin Tan; Tieqi Li; Jingang Ai; Yexun Song; Zheng Zhou; Jian Xiao; Wei Li
Journal:  PeerJ       Date:  2021-07-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.